Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. - Derosa,G.; Cicero,A.F.; Gaddi,A. (Clin Ther, 2004)